Armata Pharmaceuticals (ARMP) Cash & Current Investments (2016 - 2018)
Historic Cash & Current Investments for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q3 2018 value amounting to $13.4 million.
- Armata Pharmaceuticals' Cash & Current Investments rose 7337.22% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.4 million, marking a year-over-year increase of 7337.22%. This contributed to the annual value of $5.1 million for FY2017, which is 0.0% changed from last year.
- Latest data reveals that Armata Pharmaceuticals reported Cash & Current Investments of $13.4 million as of Q3 2018, which was up 7337.22% from $15.4 million recorded in Q2 2018.
- In the past 5 years, Armata Pharmaceuticals' Cash & Current Investments ranged from a high of $16.6 million in Q1 2015 and a low of $2.2 million during Q1 2017
- In the last 5 years, Armata Pharmaceuticals' Cash & Current Investments had a median value of $9.0 million in 2017 and averaged $9.5 million.
- Over the last 5 years, Armata Pharmaceuticals' Cash & Current Investments had its largest YoY gain of 218581.36% in 2014, and its largest YoY loss of 6766.89% in 2014.
- Armata Pharmaceuticals' Cash & Current Investments (Quarter) stood at $6.6 million in 2014, then skyrocketed by 42.38% to $9.4 million in 2015, then plummeted by 45.23% to $5.1 million in 2016, then changed by 0.0% to $5.1 million in 2017, then surged by 160.97% to $13.4 million in 2018.
- Its Cash & Current Investments was $13.4 million in Q3 2018, compared to $15.4 million in Q2 2018 and $8.2 million in Q1 2018.